VASO VASO Dashboard

Risks

• The impact of the COVID-19 pandemic on our markets and financial condition is difficult to predict and manage.
• Achieving profitable operations is dependent on several factors
• We currently derive a significant amount of our revenue and operating income from our agreement with GEHC.
• We face competition from other companies and technologies.
• We depend on management and other key personnel.
• We may not continue to receive necessary FDA clearances or approvals, which could hinder our ability to market and sell certain products.
• We have foreign operations and are subject to the associated risks of doing business in foreign countries.
• We depend on several suppliers for the supply of certain products.
• We may not have adequate intellectual property protection.
• The loss or violation of certain of our patents and trademarks could have a material adverse effect upon our business.
• Our growth could suffer if the markets into which we sell products decline, do not grow as anticipated or experience cyclicality.
• Technological change is difficult to predict and to manage.
• We are subject to product liability claims and product recalls that may not be covered by insurance.
• We do not know the effects of healthcare reform proposals.
• The application of the "penny stock" rules could adversely affect the market price of our common stock and increase your transaction costs to sell those shares.
• Our common stock is subject to price volatility.
• We do not intend to pay dividends in the foreseeable future.